Core Scientific, Inc.CORZNASDAQ

Revenue (LTM)

$319M

-37.5% YoY

Net Income (LTM)

$-289M

+78.1% YoY

Free Cash Flow

$-451M

Revenue CAGR (5Y)

+39.5%

Marginsdeclining

FCF($0.5B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	544	640↑17.6%	502↓21.5%	511↑1.6%	319↓37.5%
Gross Profit	239	8↓96.5%	123↑1369.8%	121↓1.9%	38↓68.7%
Operating Income	167	-2,110↓1365.9%	9↑100.4%	-19↓314.2%	-145↓653.8%
Net Income	47	-2,146↓4636.5%	-246↑88.5%	-1,315↓433.5%	-289↑78.1%
EBITDA	141	-1,840↓1407.2%	-63↑96.6%	-1,157↓1732.9%	-76↑93.4%
EPS Diluted	0.20	-6.30↓3250.0%	-0.65↑89.7%	-5.14↓690.8%	-0.88↑82.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	118	16↓86.5%	50↑217.4%	836↑1558.8%	311↓62.8%
Total Current Assets	757	85↓88.8%	97↑14.0%	904↑831.8%	896↓0.9%
Total Assets	2,439	808↓66.9%	712↓11.8%	1,599↑124.5%	2,348↑46.8%
Total Current Liabilities	320	187↓41.7%	488↑161.5%	135↓72.4%	781↑480.7%
Total Liabilities	1,098	1,217↑10.9%	1,309↑7.6%	2,419↑84.8%	3,310↑36.8%
Total Equity	1,341	-409↓130.5%	-597↓45.8%	-820↓37.4%	-963↓17.4%
Total Debt	819	38↓95.4%	866↑2194.0%	1,200↑38.6%	1,060↓11.6%
Net Debt	701	22↓96.9%	815↑3631.1%	364↓55.4%	749↑106.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-57	205↑461.7%	65↓68.3%	43↓34.1%	278↑548.7%
Capital Expenditure	-59	-602↓915.0%	-16↑97.3%	-95↓487.6%	-729↓667.7%
Free Cash Flow	-116	-396↓241.8%	49↑112.3%	-52↓206.4%	-451↓765.7%
Stock-Based Comp	39	183↑369.7%	59↓67.8%	52↓11.8%	98↑89.2%
Net Change in Cash	123	-79↓164.6%	17↑122.0%	767↑4292.2%	-526↓168.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance